Inovio Pharmaceuticals Inc. Stock Falls 4.8%, Underperforms Peers
Dow Jones2026/10/16 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. shed 4.8% to $0.99 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.1% to 26,140.03 and Dow Jones Industrial Average falling 0.3% to 52,002.41.
Inovio Pharmaceuticals Inc. closed 63.6% below its 52-week high of $2.72, which the company reached on December 17th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.9% to $255.56, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.48% to $29.58.
Trading volume totaled 2.0 million, compared to the 50-day average of 3.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 16, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.
The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.
Turtle Creek Asset Management Reports Sale of $347,850 in Jeld-Wen Common Shares
GLOBALFOUNDRIES Director Ganesh Moorthy Reports $93,687.50 Share Acquisition
Crypto prices
More
